ERBB2 and breast carcinoma: Strikingly, as showed in Figure 6A, we found high DCUN1D5 mRNA expression levels in high-metastatic triple-negative (TNBC) and HER2 positive breast cancers compared to low-metastatic luminal tumors annotated in the TCGA-BRCA dataset.